3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Philadelphia Chromosome
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Recurrence
1
Peritoneal Neoplasms
1
Leukemia
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Blast Crisis
1
Appendiceal Neoplasms
1
Interventions
pertuzumab
2
Trastuzumab
2
Taxes
2
Standard of Care
2
Practice Guidelines as Topic
2
Paclitaxel
2
High-Energy Shock Waves
2
Docetaxel
2
trastuzumab biosimilar HLX02
1
Transcutaneous Electric Nerve Stimulation
1
Specimen Handling
1
Radiation Dose Hypofractionation
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Minoxidil
1
Methods
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Educational Status
1
Early Intervention, Educational
1
Disulfides
1
Carboplatin
1
Biopsy
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
nilotinib
×
30 days
×
Clear all
No trials found.